Newsroom

Recent News Releases

February 4, 2023 2/4/2023

U.S. FDA Approves Takeda’s TAKHZYRO^® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

February 2, 2023 2/2/2023

Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions
Delivers Another Strong Quarter in FY2022 Q3

January 24, 2023 1/24/2023

Takeda to Hold Third Quarter FY2022 Earnings Call on February 2

January 23, 2023 1/23/2023

Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor

January 17, 2023 1/17/2023

Takeda Named Global Top Employer for Sixth Consecutive Year

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Luck is not a strategy: The world needs to start preparing now for the next pandemic

Learn more

The COVID-19 Mental Burden on Working Mothers

Learn more

Takeda Neuroscience at the Annual Meeting of the American Academy of Neurology (AAN) 2021

Learn more

Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts

Learn more

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.